ArticleClinical breast cancer2025
Trends in Incidence of Invasive Lobular Carcinoma of the Breast by Race: Patterns by Age, Cancer Stage, and Socioeconomic Factors in the United States, 1992-2019.
Article in Clinical breast cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lobular breast cancer statistics, 2025.Cancer · 2025Article
- Socioeconomic status impacts tumor biology, treatment, and outcomes in over 200,000 patients with invasive lobular carcinoma of the breast: an analysis of the National Cancer Database.Breast cancer research and treatment · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeThere is scarce literature about the role of race/ethnicity and socioeconomic status on the incidence of invasive lobular carcinoma (ILC). We sought to assess trends in ILC incidence by race/ethnicity across age, cancer stage, and socioeconomic status subgroups in the United States from 1992 to 2019.
methodsThis population-based cross-sectional study included data from SEER12 registries. We used the NCI's Join point Regression Program to estimate longitudinal trends in age-adjusted breast cancer incidence rates from 1992 to 2019, reported as average annual percent change (AAPC) or annual percent change (APC). We evaluated incidence trends by a combination of race/ethnicity and stage, county-level poverty, county-level metro/nonmetro status, high school education, and age.
resultsFrom 1992 to 2019, ILC incidence rates increased across all race/ethnicity groups, with the greatest increase in non Hispanic Black (AAPC 2.6%), followed by Hispanic (AAPC 2.2%), and non Hispanic White women (AAPC 1.6%). The stronger increase in ILC incidence among Hispanic and non Hispanic Black women was predominantly seen among those living in low poverty or metropolitan areas and those older than 70. In recent years, from 2002 to 2019, the largest increase in ILC incidence was found in Hispanic women (APC 3.3%).
conclusionAlthough the incidence of ILC continues to be highest in non Hispanic White women, in recent years the largest increases are seen in non Hispanic Black women and Hispanic women. Further research is warranted to better understand these trends and appropriately target at-risk populations for screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.